HAWTHORNE, N.Y.--(BUSINESS WIRE)--Taro Pharmaceutical Industries Ltd. (“Taro,” PINK SHEETS: TAROF) reported today that it has received final approval from the U.S. Food and Drug Administration (“FDA”) ...
TORONTO and CHICAGO, March 22, 2023 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals (TSX: MDP; OTCQX: MEDXF) is pleased to announce that the company has secured Canadian rights to commercialize ...
Adults: Toenail- 250 mg once daily for 12 weeks. Cream: Local application once or twice daily over the affected skin area. For the above reasons, Medindia cannot be held liable for any action taken ...
If and when approved, the product will enter the topical fungicides market that is estimated to be C$88 million on an annual basis* Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - January 8, ...
July 13, 2007 — The US Food and Drug Administration (FDA) has approved first-time generic formulations for paroxetine hydrochloride extended release tablets, 12.5 mg and 25 mg, for the treatment of ...
The FDA today approved the first generic versions of Novartis’ Lamisil (terbinafine hydrochloride) tablets, used to treat nail fungus infection (onychomycosis). The agency approved applications from ...
Terbinafine (Binadis Cream) is an antifungal agent, prescribed for jock itch, athlete's foot and other types of ringworm infections.It works by stopping the growth of fungi. The information provided ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results